NEW JERSEY — Patients For Affordable Drugs Now announced it will extend its campaign thanking Reps. Andy Kim (NJ-03), Tom Malinowski (NJ-07), and Mikie Sherrill (NJ-11) for supporting H.R. 3, and calling on Rep. Josh Gottheimer (NJ-05) to support the bill that would lower drug prices by allowing Medicare to negotiate on behalf of New Jerseyans. The new phase of the campaign will start July 2 and will include digital video ads as well as grassroots advocacy, in which constituents will directly contact Reps. Kim, Malinowski, Sherrill, and Gottheimer to ask them to stand with patients against Big Pharma.

“H.R. 3 will ensure New Jerseyans have access to affordable medicine while protecting innovation for the future,” said David Mitchell, a cancer patient and founder of Patients For Affordable Drugs Now. “Patients need Rep. Gottheimer to stand up to Big Pharma and join Reps. Kim, Malinowski, and Sherrill in pushing for this important legislation to lower the price of prescription drugs for Americans.”

The expanded push will include new video ads highlighting Steven Hadfield, a patient from Charlotte, North Carolina, who lives with a rare blood cancer and is prescribed a medication priced at $132,000 a year. The ads thank Reps. Kim and Malinowski for supporting H.R. 3 and urge constituents to ask them to keep fighting for lower drug prices. 

“I’ve been fighting it for seven years,” Steven says in the ads playing on digital platforms. “$132,000. That’s the annual price for my cancer medication. I live in fear over my high drug prices. You wonder how everybody else survives.”

You can watch the video ad in NJ-03 here
You can watch the video ad in NJ-07 here

The following digital ad will run in NJ-11 to thank Rep. Sherrill for standing with patients and to remind her to push for passage of H.R. 3. 

The following digital ad will run in NJ-05 to urge Rep. Gottheimer to stand with patients and push for passage of H.R. 3. 

P4ADNow’s campaign to support H.R. 3 was first launched on May 20 on the heels of Big Pharma’s attack ads loaded with lies, pressuring members of Congress not to support H.R. 3.

H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, was reintroduced in the House of Representatives in April. The chamber passed the bill in the 116th Congress. It will lower prices, rein in price gouging, and reduce out-of-pocket costs by restoring balance to the U.S. drug pricing system to ensure both innovation and affordability.

The New Jersey campaign is part of Patients For Affordable Drugs Now’s national campaign across 44 House districts.